Pooled data from 91 trials finds no added suicide risk with GLP-1 drugs
Researchers in Drugs & Therapy Perspectives looked at nearly 108,000 participants and saw the same rate of suicidal ideation or behavior on GLP-1s as on placebo.
Recap by typeshit. Full story at BIOENGINEER.